Drug Trials Snapshots – HYMPAVZI
HYMPAVZI is a drug used to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B. It is to be used in patients who have not developed an immune response known as factor VIII or factor IX inhibitors or antibody. Hemophilia A and hemophilia B…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
